1. Comparative Pharmacokinetic Study of Taxifolin after Oral Administration of Fructus Polygoni Orientalis Extract in Normal and Fibrotic Rats by UPLC-MS/MS
   Feili Wei et al, 2019, Evidence-Based Complementary and Alternative Medicine CrossRef
2. Evaluation of the Mechanism of Jiedu Huazhuo Quyu Formula in Treating Wilson’s Disease-Associated Liver Fibrosis by Network Pharmacology Analysis and Molecular Dynamics Simulation
   Shao-Peng Huang et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
3. Fluorofenidone Alleviates Renal Fibrosis by Inhibiting Necroptosis Through RIPK3/MLKL Pathway
   Qin Dai et al, 2020, Frontiers in Pharmacology CrossRef
4. Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy
   Zui Tan et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
5. Puerarin Ameliorates Caerulein-Induced Chronic Pancreatitis via Inhibition of MAPK Signaling Pathway
   Xiang-Peng Zeng et al, 2021, Frontiers in Pharmacology CrossRef
6. Fluorofenidone alleviates liver fibrosis by inhibiting hepatic stellate cell autophagy via the TGF-β1/Smad pathway: implications for liver cancer
   Xiongqun Peng et al, 2023, PeerJ CrossRef
7. Integrating Network Pharmacology and Experimental Validation to Investigate the Effects and Mechanism of Astragalus Flavonoids Against Hepatic Fibrosis
   Lin An et al, 2021, Frontiers in Pharmacology CrossRef
8. Current investigations for liver fibrosis treatment: between repurposing the FDA-approved drugs and the other emerging approaches
   Omima S. Mohammed et al, 2023, Journal of Pharmacy & Pharmaceutical Sciences CrossRef